Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil QoL in ED patients previously treated with other oral therapy
NCT00422578Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tadalafil in erectile dysfunction (ED), sponsored by Eli Lilly and Company. Primary endpoint: Psychological and Interpersonal Relationship Scales - Spontaneity Domain at 13 weeks. Started Oct 2004; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00422578.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422578.